UBS raised the firm’s price target on Bath & Body Works to $22 from $21 and keeps a Neutral rating on the shares. The firm sees a balanced upside/downside skew into the Q4 earnings report, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBWI:
- Bath & Body Works officially launches in Amazon’s U.S. stores
- Dollar General downgraded, Dollar Tree upgraded: Wall Street’s top analyst calls
- Bath & Body Works (BBWI) Stock Slides on ‘Weak’ Core Business
- Citi downgrades Bath & Body to Neutral on ‘weak’ core business
- Bath & Body Works downgraded to Neutral from Buy at Citi